Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Entropy (Basel, Switzerland)
|
July 2, 2021
A Semi-Deterministic Random Walk with Resetting
Javier Villarroel, Miquel Montero, Juan Antonio Vega
European Journal of Medicinal Chemistry
|
December 28, 2014
N-Bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders
Oscar Delgado, Francisca Delgado, Juan Antonio Vega, et al.
Medicina Clinica
|
March 20, 2004
[Assessing COPD-associated morbidity: factors of prognosis]
Juan Antonio Vega Reyes, Manuel Montero Pérez-Barquero, Pedro Sánchez Guijo
ACS Medicinal Chemistry Letters
|
March 19, 2020
Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1<i>H</i>-benzimidazol-2-ones as mGlu<sub>2</sub> Receptor PAMs
Ana Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 11, 2011
Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors
Gary Tresadern, Francisca Delgado, Oscar Delgado, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2009
Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor
Gary Tresadern, Jose María Cid, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry
|
February 23, 2012
Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor
Andrés A Trabanco, Gary Tresadern, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry
|
October 18, 2012
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor
Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry
|
September 1, 2016
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)
Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads
Daniel Oehlrich, Aldo Peschiulli, Gary Tresadern, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Entropy (Basel, Switzerland)
|
July 2, 2021
A Semi-Deterministic Random Walk with Resetting
Javier Villarroel, Miquel Montero, Juan Antonio Vega
European Journal of Medicinal Chemistry
|
December 28, 2014
N-Bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders
Oscar Delgado, Francisca Delgado, Juan Antonio Vega, et al.
Medicina Clinica
|
March 20, 2004
[Assessing COPD-associated morbidity: factors of prognosis]
Juan Antonio Vega Reyes, Manuel Montero Pérez-Barquero, Pedro Sánchez Guijo
ACS Medicinal Chemistry Letters
|
March 19, 2020
Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1<i>H</i>-benzimidazol-2-ones as mGlu<sub>2</sub> Receptor PAMs
Ana Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 11, 2011
Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors
Gary Tresadern, Francisca Delgado, Oscar Delgado, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2009
Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor
Gary Tresadern, Jose María Cid, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry
|
February 23, 2012
Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor
Andrés A Trabanco, Gary Tresadern, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry
|
October 18, 2012
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor
Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry
|
September 1, 2016
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)
Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads
Daniel Oehlrich, Aldo Peschiulli, Gary Tresadern, et al.
Page
of 2